One Year On… ICH Q3D Guidelines Revision
It’s been over a year since the ICH Q3D guidelines were updated to include cutaneous and transcutaneous limits…
It’s been over a year since the ICH Q3D guidelines were updated to include cutaneous and transcutaneous limits…
Resolian, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, has opened its new 20,000-square-foot (1,858-square-meter) bioanalytical laboratory, Resolian Bioanalytics Pty, Ltd., in Brisbane, Australia.
Experts in offering you bioanalytical solutions using LC-MS/MS technology.
Offering full bioanalytical and PK/TK support for all stages of drug development.
A global team of professionals proficient in GLP, GCP, cGMP, and CSV standards, with expertise in GxP-compliant quality systems.
Our bioanalysis, logistics, and sample management teams work together to provide an integrated service for global, multi-center clinical studies for our clients.
Copyright © 2024 Resolian Inc. All rights reserved.
Chief Scientific Officer
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Chief Executive Officer
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.